BJH - 2018, issue Abstract Book BHS, february 2018
A. Capes , F. Dall’Armellina , Y. Berners , L. Maindiaux , T. Connerotte , A. Camboni MD, PhD, P. Saussoy MD, PhD, J-P. Defour PhD, X. Poiré MD, N. Straetmans MD, PhD, M-C. Vekemans MD
BJH - 2018, issue Abstract Book BHS, february 2018
L. Maindiaux , F. Dall’Armellina , Y. Berners , A. Capes , V. Gillion , J. Lelotte , L. Marot , J-P. Defour PhD, M-C. Vekemans MD
BJH - 2018, issue Abstract Book BHS, february 2018
S. Amat , M-C. Vekemans MD, J-P. Defour PhD, J.C. Yombi , I. Stoian , S. Bailly MD
BJH - 2018, issue Abstract Book BHS, february 2018
Y. Berners , A. Capes , F. Dall’Armellina , L. Maindiaux , J. Morelle , K. Claes , C. Lambert MD, X. Poiré MD, M-C. Vekemans MD
BJH - 2018, issue Abstract Book BHS, february 2018
S. Bailly MD, Y. Breners , S. Amat , L. Maindiaux , F. Dall’Armellina , C. Galant , A. Camboni MD, PhD, M. Coyette , E. Van den Neste MD, PhD, M-C. Vekemans MD
BJH - 2018, issue Abstract Book BHS, february 2018
F. Dall’Armellina , Y. Berners , L. Maindiaux , A. Capes , J-P. Defour PhD, P. Saussoy MD, PhD, V. Havelange MD, PhD, M-C. Vekemans MD
BJH - volume 8, issue 2, march 2017
M-C. Vekemans MD, K. Beel MD, PhD, J. Caers MD, PhD, N. Meuleman MD, PhD, G. Bries MD, PhD, H. Demuynck MD, B. De Prijck MD, H. De Samblanx MD, A. Deweweire MD, K. Fostier MD, A. Kentos MD, P. Mineur MD, M. Vaes MD, I. Vande Broek MD, PhD, A. Vande Velde MD, J. Van Droogenbroeck MD, PhD, P. Vlummens MD, K.L. Wu MD, PhD, R. Schots MD, PhD, M. Delforge MD, PhD, C. Doyen MD, PhD, On behalf of the Multiple Myeloma Study Group of the Belgian Haematology Society (BHS)
The prognosis for multiple myeloma patients has improved substantially over the past decade with the development of more effective chemotherapeutic agents and regimens that possess a high level of anti-tumour activity. However, nearly all multiple myeloma patients ultimately relapse, even those who experience a complete response to initial therapy. Management of relapsed disease remains a critical aspect of multiple myeloma care and an important area of ongoing research. This manuscript from the Belgian Haematology Society multiple myeloma subgroup provides some recommendations on the management of relapsed disease.
(BELG J HEMATOL 2017;8(2):53–65)
Read more
Top
